LASERSKIN autograft

ktc_lsk1 .jpg (12458 byte)
Keratinocytes growing on LASERSKIN

ktc_lsk2.jpg (9393 byte)
Keratinocytes migrate through LASERSKIN  microperforation and
reach the wound bed, where they form thousand of re-epithelialization
islets, guaranteeing an extremely rapid coverage of the wound

LASERSKIN, the first biomaterial for tissue engineering to be approved by the European Union, has been designed to allow the early grafting of actively proliferating keratinocytes.

LASERSKIN is a trasparent, biodegradable membrane, consisting entirely of an ester of Hyaluronic acid (HYAFF), one of the major components of the extracellular matrix.

Thanks to its particular structure, with orderly arrays of laser-drilled microperforations, LASERSKIN enables the cultures to be grafted even before they have reached confluence.

The microperforation allow to transfer onto the wound bed actively proliferating, preconfluent autologous keratinocytes, ready to take and to ensure a rapid re-epithelialization.

LASERSKIN autograft ready for grafting

HYAFF®, Laserskin®, Hyalograft 3D® are trademarks of FAB, Fidia Advanced Biopolymers srl

Fidia Advanced Biopolymers Srl - Via Ponte della Fabbrica, 3/a - 35031 Abano Terme PD - Italy
Phone ++39 049 8232523 - Fax ++39 049 8232752
Toll-free number: 800-204161 - e-mail: infofab@fidiapharma.it

it's a ISO 9001 certified company